FOI release

Freedom of Information request on the MHRA's attendance at the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) meetings in April 2021 (FOI 21-488)

Published 13 August 2021

11th June 2021 FOI 21/488

Dear

Thank you for your email and we apologise for delay in response.

You asked whether we attended any meetings of the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) in April 2021. I can confirm that we attended the 6-9 April PRAC meeting on the following days as observers:

• 6 April • 7 April

Highlights of the meeting can be found on the EMA website: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-6-9-april-2021

If you have a query about the information provided, please reply to this email.

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review.

Internal review requests should be submitted within two months of the date you receive this response and addressed to: info@mhra.gov.uk

Please remember to quote the reference number above in any future communications. Please note, due to the ongoing Covid-19 situation, we are not able to accept delivery of any documents or correspondence by post or courier to any of our offices.

If you were to remain dissatisfied with the outcome of the internal review, you would have the right to apply directly to the Information Commissioner for a decision. Please bear in mind that the Information Commissioner will not normally review our handling of your request unless you have first contacted us to conduct an internal review. The Information Commissioner can be contacted at:

Information Commissioner’s Office Wycliffe House Water Lane Wilmslow Cheshire SK9 5AF

Yours sincerely,

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency 10 South Colonnade, Canary Wharf, London E14 4PU